Sign In
Buy EYEN
$7.56
+0 (+0%)
At Close: Jan 16, 2026
Eyenovia Reports First Quarter 2020 Financial Results
08:05pm, Wednesday, 13'th May 2020
NEW YORK, May 13, 2020 -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its.
The Daily Biotech Pulse: Gilead Signs Manufacturing Deal For Remdesivir, Bristol-Myers Gets Refuse-To-File Letter
12:00am, Wednesday, 13'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 12)
Acceleron Pharma Inc (NASDAQ...
The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The Spotlight
12:00am, Sunday, 10'th May 2020
The smid-cap biotech earnings deluge hit Wall Street in the week ended May 9, positively impacting the stocks in the sector. The iShares NASDAQ Biotechnology Index (NASDAQ: IBB)...
8-K: EYENOVIA, INC.
06:01am, Saturday, 09'th May 2020
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________ FORM 8-K __________________ CURRENT REPORT Pursuant to Section 13...
Eyenovia Announces Conference Call and Webcast for First Quarter 2020 Financial Results
12:30pm, Wednesday, 06'th May 2020
NEW YORK, May 06, 2020 -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its.
Will Eyenovia Continue to Surge Higher?
02:10pm, Wednesday, 22'nd Apr 2020
As of late, it has definitely been a great time to be an investor Eyenovia
Daily Insider Ratings Round Up 3/25/20
02:25pm, Friday, 27'th Mar 2020
Tables of the top insider purchases and sales filed with the SEC on 3/25/20, based on dollar value. Dollar values often do not equate with significance when it
Insider Buying: Stuart Grant Just Spent US$1.9m On Eyenovia, Inc. (NASDAQ:EYEN) Shares
10:31am, Thursday, 26'th Mar 2020
Eyenovia, Inc. (NASDAQ:EYEN) shareholders (or potential shareholders) will be happy to see that insider Stuart Grant...
Eyenovia (EYEN) Receives a Hold from Oppenheimer
08:59am, Thursday, 26'th Mar 2020
Oppenheimer analyst Esther Rajavelu maintained a Hold rating on Eyenovia (EYEN) today. The company's shares closed last Monday at $2.34. According to
Eyenovia (EYEN) Receives a Hold from Oppenheimer
08:59am, Thursday, 26'th Mar 2020
Oppenheimer analyst Esther Rajavelu maintained a Hold rating on Eyenovia (EYEN – Research Report) today. The company’s shares closed last
Eyenovia Reports Fourth Quarter and Full Year 2019 Financial Results
08:05pm, Wednesday, 25'th Mar 2020
NEW YORK, March 25, 2020 -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its.
Eyenovia, Inc. to Host Earnings Call
06:30pm, Wednesday, 25'th Mar 2020
NEW YORK, NY / ACCESSWIRE / March 25, 2020 / Eyenovia, Inc. (NASDAQ:EYEN) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on March 25, 2020 at 4:30 PM E
The Daily Biotech Pulse: T2 Biosystems Licenses COVID-19 Test, Immuron CEO Steps Down
11:29am, Wednesday, 25'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 24) * BELLUS Health Inc (NASDAQ: BLU) * Global Cord
Eyenovia, Inc. Announces Closing of Approximately $6.0 Million Private Placement
09:10pm, Tuesday, 24'th Mar 2020
Eyenovia, Inc. (EYEN) a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its patented piezo-print technology, announced that today it clo
Eyenovia, Inc. Announces Approximately $6.0 Million Private Placement
10:35pm, Monday, 23'rd Mar 2020
Eyenovia, Inc. (EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its patented piezo-print technology, today announced that it has
